Envoy Medical (COCH) Preferred Stock Liabilities (2021 - 2026)

Envoy Medical has disclosed Preferred Stock Liabilities across 5 years of filings, most recently posting $391000.0 for Q2 2026.

• In Q2 2026, Preferred Stock Liabilities changed N/A year-over-year to $391000.0; the TTM figure through Jun 2026 stood at $391000.0 (changed N/A YoY), while the FY2025 annual figure was $391000.0, changed N/A from the prior year.
• Preferred Stock Liabilities came in at $391000.0 for Q2 2026 at Envoy Medical, roughly flat from $391000.0 in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $429.7 million in Q4 2022 to a low of $130000.0 in Q3 2025.
• Average Preferred Stock Liabilities over 4 years is $179.7 million, with a median of $44.4 million recorded in 2023.
• Year-over-year, Preferred Stock Liabilities climbed 1.19% in 2022 and plunged 89.61% in 2023.
• Over 4 years, Preferred Stock Liabilities stood at $429.7 million in 2022, then slumped by 89.62% to $44.6 million in 2023, then tumbled by 99.12% to $391000.0 in 2025, then changed by 0.0% to $391000.0 in 2026.
• Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $391000.0 in Q2 2026, $391000.0 in Q1 2026, and $391000.0 in Q4 2025.